NO Debt - PCR Lab - w/Equipment & Payor Contracts

Business Overview
Laboratory LLC is a clinical diagnostic laboratory specializing in polymerase chain reaction (PCR) testing. The lab was purchased during the COVID‑19 pandemic after an investment of $3–4 million and now focuses on high‑margin PCR assays (Respiratory Pathogen Panel, urinary tract infection, wound and nail panels) across 20–30 states. It is accredited by CLIA and COLA and operates a turnkey facility with modern equipment, a certified laboratory information system (Stratus LIS) and experienced staff.
Investment Highlights
• Accredited & compliant: CLIA‑certified and COLA‑accredited laboratory; certificate current through 2026.
• Modern equipment & no debt: Multi‑ and single‑channel pipettes, biosafety hoods, master mix DeadAir boxes and PCR workstations; equipment purchased with cash and calibrated regularly.
• Stable payer base: In‑network with Medicare/Medicaid across TX, AZ, NC, PA, NV, CO, MI, CA, HI, VA & IN; no clawbacks or recoupments.
• Experienced team: Lab supervisor and lab director supported by three lab employees, one salaried sales representative and three commission‑based sales reps in the valley; staff willing to remain post‑transaction.
Financial Summary (approx.)
• Current volume: ~100 PCR tests/month with average reimbursement of $600/test, generating approx. $720k in annual revenue.
• Profit margin: Approximately 40 % EBITDA after laboratory overhead and a 6 % third‑party billing fee.
• Potential upside: With 13k tests/month from the new sales rep, revenue could scale dramatically if realized.
• Debt: None; all equipment purchased with cash; no outstanding loans or lawsuits.
Transaction Details
Asking Price: $1.5 MM (asset sale)
Structure: Turnkey laboratory including equipment, CLIA & COLA licenses, payer contracts and staff.